Analyst Consensus ?
ConsensusBuy21 ratings
Bullish1781.0%
Neutral419.0%
Bearish00.0%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Expand Energy Corporation complete analyst coverage
Expand Energy Corporation (EXE) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$94.83Previous close
$87Low
$126.19Average
$150High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Raymond James | Strong Buy | Strong Buy | Maintain | Sep 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Aug 26, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 19, 2026 |
| Johnson Rice | Accumulate | Buy | Maintain | Aug 17, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 17, 2026 |
| Benchmark | Buy | Buy | Maintain | Aug 12, 2026 |
| UBS | Buy | Buy | Maintain | Jul 30, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 9, 2026 |
| William Blair | Market Perform | Outperform | Downgrade | Apr 30, 2026 |
| Keybanc | Overweight | Downgrade | Apr 2, 2026 | |
| Piper Sandler | Overweight | Overweight | Maintain | Mar 12, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Feb 18, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 8, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 5, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Dec 12, 2025 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Oct 9, 2025 |
| Roth Capital | Neutral | Buy | Downgrade | Aug 18, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 15, 2025 |
| TD Cowen | Buy | Hold | Upgrade | Apr 8, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 13, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Jan 14, 2025 |
Named analyst price targets
Upside is calculated against the persisted previous close $94.83. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | David Deckelbaum | $135 | $96.62 | +42.4% | Sep 9, 2026 |
| Raymond James | John Freeman | $147 | $98.19 | +55.0% | Sep 9, 2026 |
| Goldman Sachs | Analyst unavailable | $113 | $94.66 | +19.2% | Aug 26, 2026 |
| Morgan Stanley | Analyst unavailable | $129 | $96.4 | +36.0% | Aug 19, 2026 |
| Johnson Rice | Analyst unavailable | $125 | $93.62 | +31.8% | Aug 17, 2026 |
| Barclays | Analyst unavailable | $107 | $94.78 | +12.8% | Aug 17, 2026 |
| UBS | Josh Silverstein | $124 | $91.24 | +30.8% | Jul 30, 2026 |
| Roth Capital | Analyst unavailable | $93 | $93.04 | -1.9% | Jul 29, 2026 |
| Wolfe Research | Doug Leggate | $114 | $91.96 | +20.2% | Jul 29, 2026 |
| Truist Financial | Analyst unavailable | $117 | $86.74 | +23.4% | Jul 10, 2026 |
| UBS | Josh Silverstein | $127 | $87.1 | +33.9% | Jul 10, 2026 |
| Morgan Stanley | Analyst unavailable | $131 | $88.47 | +38.1% | Jun 29, 2026 |
| Barclays | Analyst unavailable | $110 | $97.94 | +16.0% | May 26, 2026 |
| Morgan Stanley | Analyst unavailable | $139 | $97.08 | +46.6% | May 22, 2026 |
| Truist Financial | Analyst unavailable | $133 | $99.5 | +40.3% | Apr 9, 2026 |
| Morgan Stanley | Analyst unavailable | $141 | $113.5 | +48.7% | Mar 27, 2026 |
| UBS | Analyst unavailable | $135 | $106.04 | +42.4% | Feb 23, 2026 |
| Wells Fargo | Analyst unavailable | $123 | $108.06 | +29.7% | Feb 23, 2026 |
| Barclays | Betty Jiang | $125 | $108.06 | +31.8% | Feb 23, 2026 |
| Jefferies | Lloyd Byrne | $141 | $99.52 | +48.7% | Feb 19, 2026 |
| Stephens | Analyst unavailable | $146 | $102.75 | +54.0% | Feb 18, 2026 |
| Piper Sandler | Analyst unavailable | $137 | $108.82 | +44.5% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $126 | $109.85 | +32.9% | Jan 21, 2026 |
| Stephens | Analyst unavailable | $140 | $99.88 | +47.6% | Jan 20, 2026 |
| UBS | Josh Silverstein | $150 | $105.61 | +58.2% | Jan 8, 2026 |
| Jefferies | Analyst unavailable | $143 | $106.66 | +50.8% | Jan 8, 2026 |
| Bernstein | Analyst unavailable | $144 | $109.77 | +51.9% | Jan 5, 2026 |
| UBS | Analyst unavailable | $154 | $113.82 | +62.4% | Dec 12, 2025 |
| Mizuho Securities | Nitin Kumar | $142 | $114.31 | +49.7% | Dec 12, 2025 |
| UBS | Analyst unavailable | $132 | $100.41 | +39.2% | Oct 30, 2025 |
| Morgan Stanley | Devin McDermott | $135 | $100.33 | +42.4% | Oct 14, 2025 |
| UBS | Josh Silverstein | $131 | $101.76 | +38.1% | Oct 13, 2025 |
| Scotiabank | Analyst unavailable | $150 | $106.84 | +58.2% | Oct 9, 2025 |
| Barclays | Analyst unavailable | $136 | $107.73 | +43.4% | Oct 7, 2025 |
| Mizuho Securities | Nitin Kumar | $136 | $95.58 | +43.4% | Sep 15, 2025 |
| Roth Capital | Analyst unavailable | $125 | $104.21 | +31.8% | Jul 30, 2025 |
| Jefferies | Lloyd Byrne | $135 | $116.46 | +42.4% | Jun 14, 2025 |
| KeyBanc | Tim Rezvan | $135 | $116.46 | +42.4% | Jun 13, 2025 |
| Stephens | Mike Scialla | $118 | $104.23 | +24.4% | Apr 15, 2025 |
| Piper Sandler | Analyst unavailable | $101 | $96.24 | +6.5% | Mar 6, 2025 |
| Barclays | Analyst unavailable | $117 | $98.88 | +23.4% | Feb 28, 2025 |
| Roth Capital | Leo Mariani | $116 | $106 | +22.3% | Jan 23, 2025 |
| Morgan Stanley | Devin McDermott | $136 | $107.35 | +43.4% | Jan 22, 2025 |
| Wolfe Research | Doug Leggate | $146 | $99.78 | +54.0% | Jan 3, 2025 |
| Citigroup | Paul Diamond | $100 | $88.7 | +5.5% | Oct 30, 2024 |
| Stephens | Mike Scialla | $86 | $85.73 | -9.3% | Oct 30, 2024 |
| Mizuho Securities | Nitin Kumar | $110 | $87.36 | +16.0% | Oct 30, 2024 |
| Stephens | Mike Scialla | $85 | $86.46 | -10.4% | Oct 17, 2024 |
| Williams Trading | Gabriele Sorbara | $87 | $86.62 | -8.3% | Oct 15, 2024 |
| Mizuho Securities | Nitin Kumar | $105 | $87.57 | +10.7% | Oct 11, 2024 |
Track every rating change on EXE the moment it posts. Free to start.
Start free